Use of Systemic Biorregulatory Medicine in an Alopecic Canine Patient Associated with Metronomic Chemotherapy for the Management of Hepatoid Cell Carcinoma
December 2021
TLDR Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.
A 12-year-old male canine diagnosed with hepatoid cell carcinoma underwent metronomic chemotherapy, resulting in gastroenteric disturbances, generalized alopecia, and loss of visual capacity. Conventional therapy over four months showed no improvement, leading to a suggestion of euthanasia. However, after one month of biorregulatory therapy, the dog exhibited significant health improvements, including recovery from gastroenteropathy, generalized folliculogenesis, and restored vision. The canine achieved full health without the need for ongoing medication and did not experience recurrence of perianal lesions during the biorregulatory therapy period.